#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Indolent systemic mastocytosis Dermatitis Prostate cancer Cervix carcinoma Hypersensitivity pneumonitis Vaginal cancer Lymphangiosarcoma Granulomatosis with polyangiitis Sickle cell disease Mixed-type liposarcoma Fontan procedure Congenital myopathy Synovitis Drug eruption Gaucher's disease type I More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Diagnostics Factor VIII deficiency – Life with Disease Adrenocortical carcinoma – Basic Information Acute respiratory distress syndrome – Life with Disease Rhabdomyosarcoma recurrent – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Ewing’s sarcoma – Basic Information Ewing’s sarcoma recurrent Optic glioma – Trials in Disease Pleural mesothelioma malignant – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propofol Golexanolone Tramadol Istradefylline INF904 Zinc Acetate Dihydrate Bevacizumab Rezafungin Acetate VHB937 ANTIMETABOLITES Levamlodipine Succinate Gadobutrol ALN-4324 Frexalimab Suvecaltamide Cisplatin SKB410 Cx-044933 Esflurbiprofen Donepezil Hydrochloride More therapies…

    Learn about Your Condition

    Leber's congenital amaurosis Retroperitoneal cancer Vascular graft thrombosis Colorectal cancer stage IV Paraganglion neoplasm Mucopolysaccharidosis II Adenomatous polyposis coli Persistent depressive disorder Endometrial cancer stage II Neonatal hyperglycaemia Eclampsia Gallbladder cancer Peritoneal abscess Alagille syndrome Liver transplant rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Sarcoidosis
    Investigated Drugs:
    • Prednisolone Sodium Phosphate
    • Xtmab-16
    • Prednisolone
    Czechia Denmark Greece Italy Poland Spain

  • Study on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary tract disorder
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    France Germany Italy Spain

  • Study on Empagliflozin for Patients with Non-Alcoholic Steatohepatitis (NASH)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • Empagliflozin
    Czechia

  • Study of ipatasertib with atezolizumab and chemotherapy in women with triple-negative breast cancer before surgery

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Ipatasertib
    • Atezolizumab
    Germany Spain

  • Study on JNJ-64042056 for Preclinical Alzheimer’s Disease in Patients

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Jnj-64042056
    Belgium France Germany Spain Sweden

  • Study on the Effects of Ketamine and Electroconvulsive Therapy in Patients with Treatment-Resistant Major Depressive Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Sodium Chloride
    Italy
Previous Page
1 … 899 900 901 902 903 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!